Liposomal amphotericin B in the treatment of systemic fungal infection in the neonate. the results of one case
Baquero Artigao, F.; Salas Hernández, S.; Quero Jiménez, J.
Anales Espanoles de Pediatria 45(2): 209-212
1996
ISSN/ISBN: 0302-4342 PMID: 8967659 Document Number: 461824
Document emailed within 1 workday
Related Documents
Sungkanuparph, S.; Sathapatayavongs, B.; Kunachak, S.; Luxameechanporn, T.; Cheewaruangroj, W. 2001: Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases Journal of the Medical Association of Thailand 84(4): 593-601Singh, G.P.; Saxena, R.K.; Priyadarshy, V. 2010: Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B Journal of the Indian Medical Association 108(1): 27-28
Fortún, J.; Pereira, E.; Martín de Argila, C.; Gil-Grandes, L. 1993: Efficacy of liposomal amphotericin in the treatment of cryptococcal meningitis in a cirrhotic patient with intolerance to conventional amphotericin Medicina Clinica 101(5): 198-199
Tollemar, J.; Ringdén, O.; Andersson, S.; Sundberg, B.; Ljungman, P.; Tydén, G. 1993: Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplantation 12(6): 577-582
Selleslag, D. 2006: A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B Acta Bio-Medica: Atenei Parmensis 77(Suppl 2): 32-35
Kotwani, R.N.; Bodhe, P.V.; Kirodian, B.G.; Mehta, K.P.; Ali, U.S.; Kshirsagar, N.A. 2003: Treatment of neonatal candidiasis with liposomal amphotericin B(L-AMP-LRC-1): phase Ii study Indian Pediatrics 40(6): 545-550
Tavil, B.ül.; Seçmeer, G.ül.; Ozen, H.; Cengiz, A.B.ül.; Unal, S.; Gürgey, A. 2008: Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B Turkish Journal of Pediatrics 50(1): 67-69
Cybulska, B.; Kupczyk, K.; Szlinder-Richert, J.; Borowski, E. 2002: Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME) Acta Biochimica Polonica 49(1): 67-75
Takatsuka, H.; Takemoto, Y.; Okamoto, T.; Fujimori, Y.; Tamura, S.; Wada, H.; Okada, M.; Kanamaru, A.; Kakishita, E. 1999: Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy Drugs under Experimental and Clinical Research 25(4): 193-200
Rapp, C.; Imbert, P.; Darie, H.; Simon, F.; Gros, P.; Debord, T.; Roué, R. 2003: Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate Bulletin de la Societe de Pathologie Exotique 96(3): 209-211
Jadhav, M.P.; Bamba, A.; Shinde, V.M.; Gogtay, N.; Kshirsagar, N.A.; Bichile, L.S.; Mathai, D.; Sharma, A.; Varma, S.; Digumarathi, R. 2010: Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial Journal of Postgraduate Medicine 56(2): 71-75
Anaissie, E.J.; Mattiuzzi, G.N.; Miller, C.B.; Noskin, G.A.; Gurwith, M.J.; Mamelok, R.D.; Pietrelli, L.A. 1998: Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion Antimicrobial Agents and ChemoTherapy 42(3): 606-611
Vincent, M.; Webster, M.H.; Pether, J.V. 1992: Liposomal amphotericin B Lancet 339(8789): 374-375
Patel, M.A.; Curtis, K.; Maguire, J.H. 1999: Liposomal amphotericin B for fever and neutropenia New England Journal of Medicine 341(15): 1153; Author Reply 1154-1155
Gokhale, P.C.; Kotwani, R.N.; Dange, S.Y.; Kshirsagar, N.A.; Pandya, S.K. 1993: Preclinical & pharmaceutical testing of liposomal amphotericin B Indian Journal of Medical Research 98: 75-78
Richardson, M. 2006: AmBisome today: expanding the perspectives on liposomal amphotericin B Acta Bio-Medica: Atenei Parmensis 77(Suppl 2): 3-4
Yamagishi, Y.; Mikamo, H. 2010: Retrospective investigation on the cases treated with liposomal amphotericin B Japanese Journal of Antibiotics 63(5): 347-364
Ferrari, P.; Chiarolanza, J.; Capriotti, T.; Garetti, E.; Venuta, A. 2001: Favorable course of cerebral candidiasis in a low-birth newborn treated with liposomal amphotericin B La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 23(3-4): 197-199
Shah, S.P.; Misra, A. 2004: Liposomal amphotericin B dry powder inhaler: effect of fines on in vitro performance Die Pharmazie 59(10): 812-813
Huang, X.-L.; Wu, J.; Su, T.-T.; Li, Y.-H.; Chen, Z.-B.; Li, C. 2014: Long-circulating liposomal daptomycin enhances protection against systemic methicillin-resistant Staphylococcus aureus infection with improved therapeutic potential Yao Xue Xue Bao 49(5): 701-710